As predictable, increased levels of Bim, alongside augmented expression of p53AIP1 and/or Bak correlated well with the enhanced Caspase-3 and PARP cleavage observed in the leukemia cells treated with the combination of PD and ATO (Fig. 5C). Here, BCL2L11 is linked to leukemia.